Monitoring peripheral immune blood cells as predictors of efficacy and toxicity in patients with solid tumors treated with checkpoint inhibitors (PEPITA)

Monitoring peripheral immune blood cells as predictors of efficacy and toxicity in patients with solid tumors treated with checkpoint inhibitors (PEPITA)

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Capofila

Ente finanziatore

IOV - IRCCS

Anno di finanziamento

2018

Unità Operativa

UOC Oncologia 2

Principal Investigator

Prof.ssa Valentina Guarneri
Scroll to Top